FDAnews Device Daily Bulletin

REGENERATION TECHNOLOGIES INC. ANNOUNCES FIRST CLINICAL IMPLANTATION OF XENOGRAFT IMPLANTS

Dec. 27, 2005
A A

Regeneration Technologies, Inc. (RTI), the Florida-based processor of orthopedic, cardiovascular and other biologic implants, today announced the first clinical implantations of its Sterling xenograft implants. Sterling interference screws have been recently implanted as tendon fixation for ACL replacement surgeries, and Sterling cancellous chips and cubes have been used as bone graft substitutes for total hip replacement revision procedures. All surgeries were successful.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/12-22-2005/0004238634&EDATE=)